Sirtex Medical Inc. Announces 33 Percent Dose Sales Growth of SIR-Spheres® microspheres in Fourth Quarter

Sirtex Medical Inc., a subsidiary of Sirtex Medical Limited , a leading manufacturer of targeted, innovative liver cancer therapies, announced dose sales of SIR-Spheres® m



from Google News, Yahoo! News, Wikinews, NY Times National News by search term http://ift.tt/Vzh566

via IFTTT